Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9856545 | 0.86 | SRC (0.43) | SRCL3MBTL1TDP1PKMCYP2C9 | |
| SCHEMBL30451960 | 0.82 | SRC (0.50) | SRCL3MBTL1TDP1CYP2C9CYP2C19 | |
| SCHEMBL11768711 | 0.80 | L3MBTL1 (0.47) | SRCL3MBTL1TDP1PKMCYP2C9 | |
| SCHEMBL9634847 | 0.80 | L3MBTL1 (0.50) | SRCL3MBTL1TDP1PKMCYP2C9 | |
| SCHEMBL2065935 | 0.79 | MEN1 (0.48) | TDP1CYP2C9CYP2C19MEN1KMT2A | |
| SCHEMBL16163141 | 0.77 | SRC (0.40) | SRCL3MBTL1TDP1PKMCYP2C9 | |
| SCHEMBL3401427 | 0.76 | SRC (0.60) | SRCL3MBTL1TDP1CYP2C9CYP2C19 | |
| SCHEMBL10965332 | 0.76 | SRC (0.43) | SRCL3MBTL1TDP1PKMCYP2C9 | |
| SCHEMBL28911324 | 0.76 | SRC (0.43) | SRCL3MBTL1TDP1PKMCYP2C9 | |
| SCHEMBL3490037 | 0.76 | SRC (0.54) | SRCL3MBTL1TDP1CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115799643-B | Nonaqueous electrolyte, lithium ion battery, battery module, battery pack, and power utilization device | 如鲲(江苏)新材料科技有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-115799643-A | Nonaqueous electrolyte solution, lithium ion battery, battery module, battery pack, and electric device | 如鲲(江苏)新材料科技有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-110028605-B | Full heterocyclic non-metallocene catalyst, preparation method and application | 北京化工大学 | 2021-11-26 | — | — | CN | disclosed |
| CN-113292722-A | Preparation method of polybenzimidazole polymer with high molecular weight and high solubility | 中国科学院上海有机化学研究所 | 2021-08-24 | — | — | CN | disclosed |
| CN-113292729-A | Preparation method of high-solubility polybenzimidazole copolymer | 中国科学院上海有机化学研究所 | 2021-08-24 | — | — | CN | disclosed |
| US-8889722-B2 | Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity, and intermediate therefor | SHIONOGI & CO., LTD. (JP) | 2014-11-18 | — | — | US | disclosed |
| EP-2184279-B1 | PHARMACEUTICAL COMPOSITION CONTAINING OPTICALLY ACTIVE COMPOUND HAVING THROMBOPOIETIN RECEPTOR AGONIST ACTIVITY AND INTERMEDIATE THEREOF | SHIONOGI & CO (JP) | 2014-11-12 | — | — | EP | disclosed |
| US-8530668-B2 | Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity, and intermediate therefor | SHIONOGI & CO., LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| US-20130217885-A1 | PHARMACEUTICAL COMPOSITION CONTAINING OPTICALLY ACTIVE COMPOUND HAVING THROMBOPOIETIN RECEPTOR AGONIST ACTIVITY, AND INTERMEDIATE THEREFOR | SHIONOGI & CO., LTD. (JP) | 2013-08-22 | — | — | US | disclosed |
| US-20100267783-A1 | PHARMACEUTICAL COMPOSITION CONTAINING OPTICALLY ACTIVE COMPOUND HAVING THROMBOPOIETIN RECEPTOR AGONIST ACTIVITY, AND INTERMEDIATE THEREFOR | EDDINGPHARM (HONG KONG) COMPANY LIMITED (CN) | 2010-10-21 | — | — | US | disclosed |
| EP-2184279-A1 | PHARMACEUTICAL COMPOSITION CONTAINING OPTICALLY ACTIVE COMPOUND HAVING THROMBOPOIETIN RECEPTOR AGONIST ACTIVITY AND INTERMEDIATE THEREOF | Shionogi&Co., Ltd. (JP) | 2010-05-12 | — | — | EP | disclosed |
| EP-0151554-A1 | Derivatives of phenylsulfonamides | CIBA-GEIGY AG (CH) | 1985-08-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267783-A1 | PHARMACEUTICAL COMPOSITION CONTAINING OPTICALLY ACTIVE COMPOUND HAVING THROMBOPOIETIN RECEPTOR AGONIST ACTIVITY, AND INTERMEDIATE THEREFOR | MPL, TEK, THPO | SRC 405/4885L3MBTL1 3953/4885TDP1 4616/4885 |
| US-20130217885-A1 | PHARMACEUTICAL COMPOSITION CONTAINING OPTICALLY ACTIVE COMPOUND HAVING THROMBOPOIETIN RECEPTOR AGONIST ACTIVITY, AND INTERMEDIATE THEREFOR | MPL, TEK, THPO | SRC 424/4885L3MBTL1 3901/4885TDP1 4593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.